Full Press Release Details
IDEAYA Biosciences Appoints Paul Stone J D as Senior Vice President and General Counsel Head of Operations and Mark Lackner Ph D as Vice President Head of Biomarkers and Synthetic Lethal Biology.
IDYA
IDEAYA Biosciences Appoints Paul Stone J D as Senior Vice President and General Counsel Head of Operations and Mark Lackner Ph D as Vice President Head of Biomarkers and Synthetic Lethal Biology
Key Takeaway: IDEAYA Biosciences Appoints Paul Stone J D as Senior Vice President and General Counsel Head of Operations and Mark Lackner Ph D as Vice President Head of Biomarkers and Synthetic Lethal Biology
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+47%
120-day peak, hindsight
Typical move
5.2%
average across 6 past catalysts
Cash runway
~42 mo
Minimal dilution risk
Lead asset
IDE892
Phase 1 · NSCLC Adenocarcinoma